New Indication: Cabozantinib Plus Nivolumab in non–Clear-Cell RCC
|New Indication: Cabozantinib Plus Nivolumab in non–Clear-Cell RCC|
J Clin Oncol. 2022 Mar 17;JCO2101944.
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Reviewed by Hasan Cagri Yildirim, MD on Mar 28, 2022
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.